๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

โœ Scribed by D. R. Gandara; Martin J. Edelman; John J. Crowley; Derick H. M. Lau; Robert B. Livingston

Publisher
Springer
Year
1997
Tongue
English
Weight
130 KB
Volume
41
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of edatrexate in small ce
Phase II trial of edatrexate in small cell lung cancer
โœ Martin Wiesenfeld; James R. Jett; John Q. Su; Theodore A. Braich; Carl G. Kardin ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 435 KB ๐Ÿ‘ 2 views
Evaluation of cisplatin, carboplatin, an
Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group
โœ Robert A. Figlin; John J. Crowley; Edwin L. Jacobs; Michael Muirhead; John Wenda ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 587 KB

## BACKGROUND. The combined use of cisplatin and carboplatin chemotherapy offers a unique means of platinum dose intensification. Response rates using either of these agents in combination with etoposide are comparable. In a Phase II trial, the authors investigated the combination of cisplatin and